If you need more lookups,
subscriptions start at $34 USD/month.
Peter Joyce Location
Oxford, GB
Peter Joyce Work
CEO and Founder @ (February 2018 - Present)
Founder and Advisor @ (November 2018 - Present)
Founder and Advisor @ (March 2021 - Present)
Senior Research Scientist @ (February 2015 - February 2018)
Research Scientist II @ (December 2012 - February 2015)
Postdoctoral Research Fellow @ (September 2009 - December 2012)
Regulatory Advisor @ (August 2008 - September 2009)
Peter Joyce Education
University of Bristol
PhD (Biochemistry and Genetics)
2004-2008
University of Bristol
BSc (Biochemistry - 1st class honours degree)
2001-2004
Peter Joyce Skills
Immunohistochemistry
Animal Models
Molecular Biology
Cell Biology
Life Sciences
Drug Discovery
Molecular Genetics
Mouse Models
Neurodegeneration
Immunofluorescence
Microscopy
Biochemistry
Disease Models
Neuroscience
Mouse Behaviour
Drug Development
Team Leadership
Management
Project Management
Rare Diseases
Pharmaceutical Industry
Translational Medicine
Tumor Immunology
Western Blotting
Public Speaking
Mouse Behavioural
PCR
Electrical Muscle Stimulation
Mouse Handling
Immunoprecipitation
Bacterial Cell Culture
Primary Cell Isolation
Electrical Muscle
Molecular Cloning
RNA biology
Sales
Mouse Behavioural Phenotyping
DNA sequencing
Mammalian Cell Culture
Fluorescence Microscopy
C. Elegans
Protein Purification
DNA extraction
RNAi
Real Time Pcr
DNA electrophoresis
Confocal Microscopy
Surgery
Strategy
Science
Peter Joyce Summary
Peter Joyce, based in Oxford, GB, is currently a CEO and Founder at Greywolf Therapeutics. Peter Joyce brings experience from previous roles at Pathios Therapeutics, ThirtyFiveBio and Vertex Pharmaceuticals. Peter Joyce holds a 2004 - 2008 PhD in Biochemistry and Genetics @ University of Bristol. With a robust skill set that includes Immunohistochemistry, Animal Models, Molecular Biology, Cell Biology, Life Sciences and more. Peter Joyce has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Peter Joyce?
Find contact details for 700 million professionals.